This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
infectious | diseases | 214 |
infectious | disease | 166 |
immune | response | 139 |
pediatric | patients | 134 |
- | time | 131 |
- | cell | 111 |
respiratory | viruses | 95 |
viral | infection | 91 |
immune | responses | 80 |
viral | infections | 75 |
- | risk | 74 |
- | infection | 54 |
high | risk | 54 |
respiratory | infections | 44 |
respiratory | virus | 42 |
- | analysis | 36 |
- | cells | 36 |
negative | . | 33 |
humans | . | 29 |
respiratory | disease | 29 |
- | year | 28 |
- | level | 26 |
immune | cells | 23 |
severe | disease | 23 |
viral | diseases | 23 |
positive | patients | 22 |
clinical | data | 22 |
negative | control | 21 |
significant | . | 21 |
- | influenza | 20 |
other | studies | 20 |
other | viruses | 20 |
first | year | 19 |
positive | results | 19 |
respiratory | diseases | 19 |
- | treatment | 18 |
higher | risk | 18 |
pediatric | patient | 18 |
respiratory | infection | 18 |
similar | results | 17 |
first | case | 16 |
positive | control | 16 |
significant | risk | 15 |
- | controlled | 14 |
- | response | 14 |
antiviral | response | 14 |
low | levels | 14 |
positive | . | 14 |
positive | cells | 14 |
viral | protein | 13 |
viral | proteins | 13 |
high | levels | 12 |
immune | cell | 12 |
- | virus | 12 |
- | therapy | 12 |
different | time | 11 |
negative | results | 11 |
old | . | 11 |
such | cases | 11 |
- | protein | 10 |
first | time | 10 |
negative | controls | 10 |
negative | patients | 10 |
human | influenza | 9 |
other | diseases | 9 |
lower | risk | 9 |
low | . | 9 |
important | . | 9 |
human | infection | 9 |
antiviral | therapy | 9 |
- | years | 9 |
- | infections | 9 |
- | control | 8 |
- | day | 8 |
clinical | response | 8 |
first | infection | 8 |
first | level | 8 |
higher | levels | 8 |
human | disease | 8 |
infectious | virus | 8 |
others | . | 8 |
other | . | 7 |
viral | disease | 7 |
such | data | 7 |
acute | infection | 7 |
lower | levels | 7 |
clinical | studies | 7 |
first | patient | 7 |
human | infections | 6 |
severe | influenza | 6 |
other | cases | 6 |
low | level | 6 |
human | viruses | 6 |
low | risk | 6 |
human | diseases | 6 |
higher | level | 6 |
high | . | 6 |
different | viruses | 6 |
different | cell | 6 |
different | . | 6 |
new | influenza | 5 |
similar | cases | 5 |
significant | results | 5 |
severe | infection | 5 |
primary | disease | 5 |
positive | result | 5 |
pediatric | cases | 5 |
other | cell | 5 |
older | patients | 5 |
human | cases | 5 |
important | risk | 5 |
highest | risk | 5 |
highest | level | 5 |
early | infections | 5 |
different | groups | 5 |
antiviral | treatment | 5 |
antiviral | responses | 5 |
- | study | 5 |
- | model | 5 |
pediatrics | . | 4 |
human | cell | 4 |
new | treatment | 4 |
other | day | 4 |
other | patient | 4 |
other | proteins | 4 |
similar | . | 4 |
positive | controls | 4 |
primary | cells | 4 |
severe | cases | 4 |
first | study | 4 |
specific | data | 4 |
high | level | 4 |
new | vaccines | 4 |
first | day | 4 |
antivirals | . | 4 |
early | time | 4 |
- | case | 4 |
- | child | 4 |
- | group | 4 |
acute | infections | 4 |
antiviral | therapies | 4 |
- | patients | 4 |
different | levels | 4 |
different | methods | 4 |
different | virus | 4 |
earlier | . | 4 |
earlier | study | 4 |
significant | response | 3 |
new | method | 3 |
new | viruses | 3 |
other | patients | 3 |
other | treatment | 3 |
other | virus | 3 |
positive | cases | 3 |
severe | infections | 3 |
viral | vaccine | 3 |
similar | data | 3 |
similar | studies | 3 |
specific | analysis | 3 |
specific | response | 3 |
specific | therapy | 3 |
specific | virus | 3 |
lower | . | 3 |
new | infections | 3 |
human | vaccines | 3 |
infectious | cases | 3 |
common | . | 3 |
- | days | 3 |
- | patient | 3 |
- | studied | 3 |
clinical | cases | 3 |
clinical | disease | 3 |
clinical | vaccine | 3 |
clinical | virus | 3 |
- | disease | 3 |
common | disease | 3 |
different | diseases | 3 |
different | models | 3 |
first | vaccine | 3 |
higher | . | 3 |
common | risk | 3 |
human | cells | 3 |
primary | infection | 2 |
similar | patients | 2 |
similar | control | 2 |
significant | disease | 2 |
severe | year | 2 |
severe | patients | 2 |
primary | method | 2 |
other | therapy | 2 |
pediatric | data | 2 |
others | studies | 2 |
other | therapies | 2 |
other | models | 2 |
other | infections | 2 |
other | groups | 2 |
similar | viruses | 2 |
similar | virus | 2 |
such | children | 2 |
specific | cell | 2 |
specific | cells | 2 |
viral | influenza | 2 |
viral | groups | 2 |
viral | control | 2 |
viral | analysis | 2 |
such | studies | 2 |
such | results | 2 |
such | patients | 2 |
such | infections | 2 |
such | diseases | 2 |
other | disease | 2 |
specific | treatment | 2 |
specific | risks | 2 |
specific | risk | 2 |
specific | diseases | 2 |
specific | disease | 2 |
other | group | 2 |
larger | studies | 2 |
other | cells | 2 |
early | studies | 2 |
early | response | 2 |
early | . | 2 |
different | studies | 2 |
different | patients | 2 |
different | influenza | 2 |
different | infection | 2 |
common | viruses | 2 |
clinical | study | 2 |
clinical | risk | 2 |
clinical | diseases | 2 |
antiviral | treatments | 2 |
acute | responses | 2 |
acute | disease | 2 |
- | analyses | 2 |
older | children | 2 |
early | results | 2 |
clinical | viruses | 2 |
early | years | 2 |
larger | study | 2 |
new | therapies | 2 |
first | cases | 2 |
new | study | 2 |
new | methods | 2 |
new | diseases | 2 |
new | cases | 2 |
lower | level | 2 |
new | data | 2 |
large | studies | 2 |
large | . | 2 |
infectious | studies | 2 |
immune | therapy | 2 |
human | patients | 2 |
higher | infection | 2 |
other | data | 1 |
other | years | 1 |
other | methods | 1 |
other | protein | 1 |
other | risk | 1 |
other | study | 1 |
other | vaccine | 1 |
other | vaccines | 1 |
positive | response | 1 |
pediatric | case | 1 |
pediatric | influenza | 1 |
pediatric | studies | 1 |
positive | cell | 1 |
positive | disease | 1 |
positive | group | 1 |
positive | infection | 1 |
primaries | . | 1 |
older | . | 1 |
older | group | 1 |
low | responses | 1 |
old | patient | 1 |
lowest | risk | 1 |
largest | virus | 1 |
low | patient | 1 |
primary | patient | 1 |
lower | cell | 1 |
lower | infection | 1 |
lower | treatment | 1 |
lowest | . | 1 |
negative | cells | 1 |
old | children | 1 |
negative | patient | 1 |
negative | result | 1 |
new | case | 1 |
new | disease | 1 |
new | models | 1 |
new | treatments | 1 |
new | vaccine | 1 |
primary | cases | 1 |
significant | result | 1 |
primary | patients | 1 |
primary | response | 1 |
similar | treatment | 1 |
specific | case | 1 |
specific | groups | 1 |
specific | infection | 1 |
specific | infections | 1 |
specific | patient | 1 |
specific | protein | 1 |
specific | responses | 1 |
specific | viruses | 1 |
such | disease | 1 |
such | infection | 1 |
such | models | 1 |
such | risk | 1 |
such | study | 1 |
such | therapies | 1 |
viral | group | 1 |
viral | treatment | 1 |
similar | therapies | 1 |
similar | result | 1 |
similar | levels | 1 |
severe | group | 1 |
primary | treatment | 1 |
respiratory | influenza | 1 |
respiratory | patients | 1 |
respiratory | therapy | 1 |
severe | . | 1 |
severe | case | 1 |
severe | diseases | 1 |
severe | groups | 1 |
similar | cells | 1 |
severe | years | 1 |
significant | cell | 1 |
significant | infection | 1 |
significant | infections | 1 |
significant | levels | 1 |
largest | group | 1 |
significant | treatment | 1 |
largest | treatment | 1 |
important | method | 1 |
larger | treatment | 1 |
larger | patient | 1 |
different | model | 1 |
different | patient | 1 |
different | proteins | 1 |
different | risk | 1 |
different | timed | 1 |
different | treatment | 1 |
earlier | disease | 1 |
earlier | treatment | 1 |
earliest | cases | 1 |
earliest | time | 1 |
early | data | 1 |
early | days | 1 |
early | disease | 1 |
early | infection | 1 |
early | levels | 1 |
early | protein | 1 |
early | proteins | 1 |
different | control | 1 |
different | analyses | 1 |
common | virus | 1 |
antiviral | cell | 1 |
- | groups | 1 |
- | levels | 1 |
- | methods | 1 |
- | proteins | 1 |
- | responses | 1 |
- | viruses | 1 |
acute | virus | 1 |
antiviral | vaccine | 1 |
common | treatment | 1 |
antiviral | vaccines | 1 |
clinical | . | 1 |
clinical | analysis | 1 |
clinical | influenza | 1 |
clinical | model | 1 |
common | cell | 1 |
common | responses | 1 |
early | treatment | 1 |
early | virus | 1 |
first | analysis | 1 |
infectious | cell | 1 |
immune | studies | 1 |
important | influenza | 1 |
important | study | 1 |
important | virus | 1 |
important | viruses | 1 |
infectious | . | 1 |
infectious | case | 1 |
infectious | patients | 1 |
humans | results | 1 |
infectious | risk | 1 |
large | case | 1 |
large | cell | 1 |
large | group | 1 |
large | groups | 1 |
large | proteins | 1 |
large | study | 1 |
immune | patients | 1 |
humans | result | 1 |
first | patients | 1 |
high | risks | 1 |
first | result | 1 |
first | results | 1 |
first | studies | 1 |
high | case | 1 |
high | cell | 1 |
high | cells | 1 |
high | influenza | 1 |
high | virus | 1 |
human | study | 1 |
higher | treatment | 1 |
higher | virus | 1 |
highest | infection | 1 |
highest | levels | 1 |
human | . | 1 |
human | case | 1 |
human | responses | 1 |
viral | vaccines | 1 |